Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
10 studies found for:    NOONAN SYNDROME 3
Show Display Options
Rank Status Study
1 Completed An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection
Condition: Hepatitis C Virus
2 Completed Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Biological: Autologous dendritic cells transduced with Ad encoding NS3
3 Recruiting Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Hepatitis;   Virus Diseases
Intervention: Biological: Autologous DC-vaccines
4 Completed
Has Results
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
Condition: Hepatitis C
5 Completed Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection
Conditions: Viral Hepatitis C;   HIV
Intervention: Drug: Sofosbuvir/Ledipasvir fixed dose
6 Unknown  Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C
Conditions: Gaucher Disease;   Hepatitis C
7 Completed Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C
Intervention: Biological: GI-5005
8 Completed
Has Results
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
Condition: Genotype 1 Chronic Hepatitis C
Interventions: Drug: GI-5005;   Drug: Pegylated Interferon and Ribavirin
9 Terminated Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
Condition: Noonan Syndrome
Intervention: Drug: rhIGF-1/rhIGFBP-3
10 Terminated GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
Condition: Chronic Hepatitis C
Interventions: Drug: GS-5885;   Drug: GS-9451;   Drug: RBV;   Drug: PEG

Study has passed its completion date and status has not been verified in more than two years.